PULSION Medical Systems SE (MUN:PUS)

MUN:PUS Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	39.99	35.8	29.66	27.95	32.06
Revenue Growth (YoY)	11.71%	20.69%	6.10%	-12.80%	25.55%
Cost of Revenue	15.79	23.39	14.38	13.05	13.11
Gross Profit	24.2	12.4	15.28	14.9	18.95
Selling, General & Admin	5.28	6.21	5.53	6.35	6.92
Research & Development	3.84	1.85	2.49	2.41	2.6
Other Operating Expenses	-0.07	-0.4	-0.01	-0.02	-0.2
Operating Expenses	9.06	7.65	8.01	8.74	9.32
Operating Income	15.14	4.75	7.27	6.16	9.63
Interest Expense	-	-	-0	-0	-0.01
Interest & Investment Income	0.36	0.27	0.03	0.06	0.14
Currency Exchange Gain (Loss)	0.03	-0	0.12	0.02	0.02
EBT Excluding Unusual Items	15.53	5.02	7.41	6.24	9.78
Asset Writedown	-	-	-	-0.07	-
Pretax Income	15.53	5.02	7.41	6.17	9.78
Income Tax Expense	0.05	-0.02	0.23	0.24	0.33
Net Income	15.48	5.03	7.19	5.93	9.45
Net Income to Common	15.48	5.03	7.19	5.93	9.45
Net Income Growth	207.68%	-30.00%	21.16%	-37.23%	90.29%
Shares Outstanding (Basic)	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8
EPS (Basic)	1.88	0.61	0.87	0.72	1.15
EPS (Diluted)	1.88	0.61	0.87	0.72	1.15
EPS Growth	207.68%	-30.00%	21.16%	-37.23%	90.29%
Dividend Per Share	-	0.880	0.880	-	-
Gross Margin	60.52%	34.65%	51.52%	53.30%	59.10%
Operating Margin	37.87%	13.26%	24.51%	22.05%	30.03%
Profit Margin	38.71%	14.06%	24.23%	21.22%	29.48%
EBITDA	16.26	16.82	17.33	8.42	-
EBITDA Margin	40.67%	47.00%	58.45%	30.11%	-
D&A For EBITDA	1.12	12.08	10.06	2.25	-
EBIT	15.14	4.75	7.27	6.16	9.63
EBIT Margin	37.87%	13.26%	24.51%	22.05%	30.03%
Effective Tax Rate	0.33%	-	3.07%	3.86%	3.33%

Updated Apr 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.